Codify — Article

WV bill revises asbestos/silica accrual rules and adds repose for mining equipment

Changes when claims accrue, treats nonmalignant and cancer claims separately, limits fear-of-disease damages, and bars long‑tail suits against MSHA‑compliant coal‑mining equipment makers.

The Brief

House Bill 5324 rewrites West Virginia’s accrual rule for asbestos and silica claims and adds a time‑bar specific to manufacturers of coal‑mining equipment made to comply with Federal Mine Safety and Health Administration (MSHA) requirements. The bill says a cause of action does not begin before the earliest of three events: a medical diagnosis of an asbestos- or silica-related impairment, discovery of facts that should prompt a reasonable person to seek such a diagnosis, or the exposed person’s death.

It also states that nonmalignant conditions are separate causes from cancer and disallows damages for fear or increased risk of future disease where state law otherwise allowed them.

Practically, the measure narrows the window for certain long‑tail product‑liability suits by establishing a 12‑year (manufacturer sale) or 10‑year (first sale to initial user), whichever is earlier, outer limit for claims against manufacturers of coal‑mining equipment that was originally produced to comply with MSHA rules, unless the manufacturer gave an express warranty extending liability. The bill preserves existing settlements and does not revive claims already time‑barred on its effective date.

At a Glance

What It Does

The bill fixes accrual to the earliest of diagnosis, discovery of facts that would lead a reasonable person to seek diagnosis, or the exposed person’s death; separates nonmalignant and cancer claims; forbids awards for fear or increased risk of future disease where state law otherwise allowed them; and imposes a 12/10‑year outer time limit for suits against manufacturers of coal‑mining equipment made to comply with MSHA rules, unless an express warranty applies.

Who It Affects

Plaintiffs who claim injury from latent asbestos or silica exposure, their attorneys, defendant manufacturers and insurers—particularly makers of coal‑mining equipment—and West Virginia trial courts managing mass or long‑latency litigation.

Why It Matters

The accrual test reshapes when latent‑disease suits can be filed and will generate fact disputes about when a reasonable person discovered actionable facts. The mining‑equipment repose narrows exposure for a subset of manufacturers and shifts litigation strategy for plaintiff counsel and defenses for insurers.

More articles like this one.

A weekly email with all the latest developments on this topic.

Unsubscribe anytime.

What This Bill Actually Does

The bill rewrites the basic clock for asbestos and silica claims so that a plaintiff cannot be deemed to have an actionable claim before the first of three events: (1) a medical diagnosis of an asbestos‑ or silica‑related impairment, (2) the plaintiff learns facts that would lead a reasonable person to obtain such a diagnosis, or (3) the exposed person dies with an asbestos‑ or silica‑related impairment. That formulation means accrual is tethered to concrete medical or discovery milestones rather than to the moment of exposure, but it also raises predictable disputes about when a reasonable person ‘‘discovered’’ relevant facts.

The draft expressly preserves the status of claims already time‑barred on the bill’s effective date and protects prior settlements and agreements from being undone. It also separates nonmalignant conditions (for example, chronic pulmonary impairment) from asbestos‑ or silica‑related cancers, treating them as distinct causes of action—an important procedural distinction that can affect pleading, damages, and proof.

The bill further bars awards for ‘‘fear or increased risk of future disease’’ in asbestos and silica cases in instances where state law otherwise might have allowed such damages, narrowing recoverable speculative harms.A second cluster of changes shields a narrow class of manufacturers from long‑tail suits: if equipment used in coal mining was manufactured to comply with MSHA requirements in effect at the time of manufacture, a plaintiff must sue within the normal limitations period and, regardless, no later than 12 years from the manufacturer’s first sale/lease/delivery or 10 years from the first sale/lease/delivery to the initial user—whichever expires earlier. That creates a statute‑of‑repose‑style outer limit for those products, but the bill preserves an express‑warranty exception that extends exposure if the manufacturer contractually promised a longer period.Together, these provisions will shift litigation practice.

Plaintiffs’ counsel will need to document diagnosis dates and what a plaintiff knew or should have known and when; defense counsel will have new grounds for early dismissal or summary judgment based on accrual or repose; and courts will see more factual disputes about discovery milestones and evidentiary fights over whether equipment was ‘‘created as a result of compliance’’ with MSHA at the time of manufacture.

The Five Things You Need to Know

1

Accrual trigger: a cause of action accrues at the earliest of (a) a medical diagnosis of an asbestos/silica impairment, (b) discovery of facts that would lead a reasonable person to obtain that diagnosis, or (c) the exposed person’s death with such an impairment.

2

Nonrevival clause: the bill explicitly does not revive claims that were already time‑barred on the statute’s effective date and preserves prior settlements and agreements.

3

Two‑disease rule: nonmalignant asbestos/silica conditions are a distinct cause from related cancers, with the bill also barring damages for fear or increased risk of future disease where state law otherwise allowed them.

4

Mining‑equipment repose: for manufacturers of coal‑mining equipment made to meet MSHA requirements at manufacture, plaintiffs must sue within the applicable limitations period and in any event within 12 years from the manufacturer’s first sale/lease/delivery or 10 years from first sale/lease/delivery to the initial user—whichever expires earlier.

5

Express‑warranty carve‑out: the 12/10‑year outer time limits do not apply if the manufacturer expressly warranted or promised a longer liability period and the action is filed within that warranty period.

Section-by-Section Breakdown

Every bill we cover gets an analysis of its key sections. Expand all ↓

(a)

Accrual rule tied to diagnosis, discovery, or death

Subsection (a) fixes accrual to concrete events: medical diagnosis, discovery of facts that would prompt a reasonable person to seek a diagnosis, or death of the exposed person. Practically, this pushes courts to evaluate when plaintiffs actually knew or should have known. Expect discovery disputes and summary‑judgment motions focused on medical records, physician testimony, and lay evidence about when plaintiffs became aware of symptoms or risk‑informing facts.

(b)

No revival of time‑barred claims

Subsection (b) bars retroactive revival: if a claim was already time‑barred on the bill’s effective date, the statute will not reopen it. This limits the bill’s reach to prospective accrual and avoids creating new liability for defendants by changing accrual rules after claims have already expired, but it will require litigation over whether particular claims were in fact time‑barred at that cut‑off.

(c)

Preservation of settlements and agreements

Subsection (c) protects prior settlements and other pre‑existing agreements from being altered by the statute. For parties with structured settlements, releases, or trust arrangements, this provides contractual certainty and reduces incentive for collateral attacks claiming the bill changed underlying rights.

2 more sections
(d)

Two‑disease rule and limits on speculative damages

Subsection (d) creates a procedural separation between nonmalignant conditions and asbestos/silica‑related cancers, treating them as distinct causes of action. It also denies recovery for fear or increased risk of future disease where state law might otherwise allow such awards—narrowing damages for prospective harms and removing an avenue of recovery often used in latency litigation.

(e)

Time limits for coal‑mining equipment manufacturers (MSHA compliance carve‑out)

Subsection (e) restricts lawsuits against manufacturers of coal‑mining equipment that was manufactured to comply with MSHA requirements: plaintiffs must bring claims within the applicable limitations period and, in any event, no later than 12 years after the manufacturer’s first sale/lease/delivery or 10 years after first sale to the initial user, whichever is earlier—unless the manufacturer expressly gave a longer warranty. This functions as a statute‑of‑repose for those products but hinges on factual proof both that the equipment was created due to MSHA compliance and on precise sales/delivery dates.

At scale

This bill is one of many.

Codify tracks hundreds of bills on Justice across all five countries.

Explore Justice in Codify Search →

Who Benefits and Who Bears the Cost

Every bill creates winners and losers. Here's who stands to gain and who bears the cost.

Who Benefits

  • Manufacturers of coal‑mining equipment: The 12/10‑year outer limits sharply reduce long‑tail exposure for equipment made to comply with MSHA requirements, lowering potential liability and insurance costs for those firms.
  • Defendant manufacturers and insurers generally: Clearer accrual rules tied to diagnosis/discovery and the bar on fear‑of‑disease damages narrow plaintiffs’ recovery theories and create early procedural grounds to dismiss stale claims.
  • Parties with prior settlements: The bill’s preservation clause protects existing settlements and releases from collateral attack, offering contractual certainty to defendants and insurers who have paid or reserved for claims.
  • West Virginia trial courts: By clarifying accrual events and imposing repose for a defined class of products, the bill may reduce the volume of long‑latency claims and the complexity of some mass‑tort dockets over time.

Who Bears the Cost

  • Exposed workers and their families: Stricter accrual mechanics and the ban on fear‑of‑future‑disease damages can reduce compensation opportunities for individuals with latent injuries or those at increased risk who lack a timely diagnosis.
  • Plaintiff attorneys concentrating on long‑latency exposure claims: The bill cuts off some long‑tail theories and will reduce the universe of viable defendants and recoverable damages, affecting contingency practices.
  • Smaller manufacturers and aftermarket suppliers: Proving compliance with MSHA at the time of manufacture or tracking first‑sale dates may be administratively burdensome; those who cannot document sales/delivery history risk earlier expiration of claims.
  • Courts and parties litigating discovery disputes: The ‘‘reasonable person’’ discovery standard and proof that equipment was made because of MSHA compliance will produce fact‑heavy disputes, increasing early litigation over discovery and summary judgment.

Key Issues

The Core Tension

The central dilemma is balancing protection for people with diseases that can appear decades after exposure against the interest of manufacturers and the courts in finality: the bill narrows long‑tail liability (favoring manufacturers and insurers and docket management) while limiting recovery avenues for exposed individuals whose diseases may not produce definitive diagnoses until late in life.

The bill trades a simpler exposure‑based accrual for a fact‑intensive diagnosis/discovery test. ‘‘Discovery that would have led a reasonable person to obtain a medical diagnosis’’ is inherently subjective, and expect extensive litigation over what a plaintiff knew or should have known and when. That will push cases into pretrial fights over medical records, medical‑expert opinions, and lay testimony, which can prolong early litigation even as the statute aims to shorten overall exposure.

The MSHA‑compliance repose is narrow on its face but ambiguous in operation. Plaintiffs will contest whether particular equipment was ‘‘created as a result of compliance’’ with MSHA requirements at the time of manufacture; manufacturers must be able to prove both the compliance linkage and exact sales or delivery dates to invoke the 12/10‑year outer limits.

The express‑warranty exception creates a second litigation axis—cases will turn on contract language and whether warranty terms were in fact ‘‘express’’ and cover the alleged injury period. Finally, the nonrevival clause and preservation of prior settlements raise evidentiary fights over which claims were time‑barred before the statute became effective and whether any releases were valid, creating short‑term administrative burdens for courts and parties.

Try it yourself.

Ask a question in plain English, or pick a topic below. Results in seconds.